Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02932449 · ClinicalTrials.gov registry record
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
A clinical trial, sponsored by Target PharmaSolutions.
- Completed
- Registry status
- 711
- Enrollment target
NCT02932449 is a clinical trial that has completed, run by Target PharmaSolutions. The registered enrollment target is 711 participants.
The verdict
NCT02932449 has completed, sponsored by Target PharmaSolutions.
- COMPLETED
- Registry status
- 711 participants
- Enrollment target
Study Summary
This is a 5-year, longitudinal, observational study of patients with PBC designed to specifically address important clinical questions that remain incompletely answered from registration trials. In addition to the study database, a bio specimen repository will also be included so that translational studies of genomics and biomarkers of response may be performed.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 711 participants |
| Start Date | 2016-10 |
| Est. Completion | 2025-01-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02932449
The ClinicalTrials.gov registry entry for NCT02932449 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 711 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Target PharmaSolutions, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02932449 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02932449 about?
NCT02932449 is a clinical study titled "A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis". This is a 5-year, longitudinal, observational study of patients with PBC designed to specifically address important clinical questions that remain incompletely answered from registration trials. In addition to the study database, a bio specimen repository will also be included so that translational ...
What is the current status of trial NCT02932449?
This trial is currently completed. The enrollment target is 711 participants. The study started on 2016-10. Estimated completion is 2025-01-23.
Who is sponsoring clinical trial NCT02932449?
This trial is sponsored by Target PharmaSolutions, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.